Pain Management (via Pharmacotherapy) - PowerPoint PPT Presentation

1 / 23
About This Presentation
Title:

Pain Management (via Pharmacotherapy)

Description:

The WHO 3-Step Model. Step 1: Mild pain (1-3/10 on pain scale) Aspirin ... The WHO 3-Step Model. Step 2: Moderate pain (4-6/10) Acetaminophen or aspirin, plus ... – PowerPoint PPT presentation

Number of Views:198
Avg rating:3.0/5.0
Slides: 24
Provided by: unmc
Category:

less

Transcript and Presenter's Notes

Title: Pain Management (via Pharmacotherapy)


1
Pain Management (via Pharmacotherapy)
  • Stephanie Riccalarsen, M.D.

2
  • Pain is an unpleasant sensory and emotional
    experience associated with actual or potential
    tissue damage.

3
Pain
  • Pain is subjective there is no test that can
    measure pain.
  • Mostly, we have to accept the patients report of
    pain, which is not always easy.
  • Perception of pain is influenced by cultural,
    psychological, and emotional factors.

4
Trying to Objectify Pain
  • Tachypnea
  • Grimace
  • Grinding/Bruxism
  • Tachycardia
  • Guarding
  • Rigidity
  • Sweating
  • Rocking
  • Clutching
  • Irritability

5
Pain
  • Acute vs. Chronic
  • Acute pain is usually related to an easily
    identified event or condition.
  • Chronic pain may or may not be related to an
    easily identified pathophysiologic phenomenon,
    may be multifactorial, and may be present for an
    indeterminate period of time.

6
Pain Classifications
  • Nociceptive pain involves direct stimulation of
    intact mechanical, chemical, or thermal
    nociceptors, and transmission of electrical
    signals along normally functioning nerves.
    (Divided into somatic and visceral.)
  • Neuropathic pain disordered function of
    peripheral or central nervous system. Responds
    best to anti-depressants and anti-convulsants,
    and occasionally with topical local anesthetics.
    Otherwise beyond the scope of this presentation.

7
Nociceptive Pain Subtypes
  • 1. Somatic skin, soft tissue, muscle, bone.
    Due to stimulation of somatic nervous system.
  • 2. Visceral cardiac, lung, GI and GU tracts.
    Results from stimulation of the autonomic nervous
    system. Patients may find this pain difficult to
    describe or localize.

8
The WHO 3-Step Model
  • Step 1 Mild pain (1-3/10 on pain scale)
  • Aspirin
  • Acetaminophen
  • Nonsteroidal Anti-Inflammatory Drugs

9
The WHO 3-Step Model
  • Step 2 Moderate pain (4-6/10)
  • Acetaminophen or aspirin, plus
  • Codeine
  • Hydrocodone
  • Oxycodone
  • Oxymorphone or
  • Tramadol (not available with aspirin, Ultracet is
    tramadol with acetaminophen)

10
The WHO 3-Step Model
  • Step 3 Severe pain (7-10/10)
  • Morphine
  • Hydromorphone (Dilaudid)
  • Methadone
  • Levorphanol
  • Fentanyl
  • Oxycodone
  • /- Nonopioid analgesics

11
It is not necessary to traverse each step
sequentially a patient with severe pain may need
to have step 3 opioids right away.
12
Acetaminophen
  • Acetaminophen is an effective step 1 analgesic.
  • It is also useful as a coanalgesic in many
    situations.
  • Its site and mechanism of action are not known.
    It is presumed to have a central mechanism.
  • It does not have signficant anti-inflammatory
    effects.

13
Acetaminophen Adverse effects
  • Doses greater than 4g per 24 hours are not
    recommended as they may cause hepatotoxicity.
  • Hepatic disease or heavy alcohol use increases
    this risk further.
  • On the outpatient basis, patients may not realize
    their Lortab, Percocet, etc., has acetaminophen
    included (it is called apap on the prescription
    bottle) and they may then take additional
    separate acetaminophen, increasing risk of
    accidental overdose and hepatotoxicity.

14
NSAIDs
  • NSAIDs are effective step 1 analgesics
  • They may also be useful coanalgesics
  • They are effective for bone and inflammatory
    pain.
  • They work in part by inhibiting cyclo-oxygenase
    (COX), the enzyme that converts arachidonic acid
    to prostaglandins.
  • All NSAIDs inhibit COX but vary in COX-2
    selectivity.
  • Ketorolac (Toradol) is available in an
    intravenous formulation

15
NSAIDs Adverse effects
  • Potential adverse effects, irrespective of route
    of administration, include gastropathy, renal
    failure, and inhibition of platelet aggregation.
  • The nonselective medications are relatively
    contraindicated in the setting of preexisting
    renal insufficiency.
  • If bleeding is a problem, or coagulation or
    platelet function is impaired, NSAIDs may be
    contraindicated.

16
Opioid Adverse Effects
  • Respiratory depression not seen when titrated
    to pain control. Pain control is generally
    achieved before respiratory depression.
  • Sedation.
  • Constipation.
  • Conjugated by the liver and excreted by kidneys,
    thus disease in either location affects dosing
    frequency and amount.

17
Opioid Pharmacology
  • Opioids reach their peak plasma concentration
    approximately
  • 60 to 90 minutes after oral or rectal
    administration
  • 30 minutes after subQ or IM injection
  • 6 minutes after intravenous administration
  • When renal clearance is normal, hydrocodone,
    hydromorphone, morphine, oxycodone, and their
    metabolites all have effective half-lives of
    about 3-4 hours.
  • When dosed repeatedly, their plasma
    concentrations approach a steady-state after 4 to
    5 half lives.

18
Selecting An Opioid
  • Extended release formulations are available but
    are not often used on an inpatient basis for
    acute pain.
  • Methadone has a long and variable half-life and
    is best used on an outpatient basis for chronic
    pain, thus it has little use on the inpatient
    service.

19
NOT RECOMMENDED
  • Meperidine (Demerol) Its principal metabolite,
    normeperidine, has no analgesic properties of its
    own, has a longer half-life of about 6 hours, is
    renally excreted, and produces significant
    adverse effects when it accumulates
    (tremulousness, dysphoria, myoclonus, and
    seizures)

20
NOT RECOMMENDED
  • Propoxyphene (Darvon) and Propoxyphene with
    acetaminophen (Darvocet) Most pain experts
    believe that these have more dependence and
    mental status risk, with rather poor pain relief
  • No better than placebo in most studies
  • Low efficacy at commercially available doses.
  • Dose escalation could lead to accumulation of a
    toxic metabolite

21
Inpatient Recommended Opioids (Intravenous)
  • Get comfortable with one or two good IV opioid
    medications, like morphine and dilaudid, and
    stick with them.
  • Remember that dilaudid is 51 more potent than
    morphine 2 mg of morphine is about equivalent to
    0.5 mg of dilaudid.
  • Common side effects include constipation, nausea,
    vomiting, itching, and skin flushing. Individual
    patients may tolerate one but not the other.

22
Commonly Used Oral Inpatient Opioids
  • Oxycodone is available in oral formulation by
    itself.
  • Percocet is oxycodone with acetaminophen,
    available with 5/325mg dosing as well as 10/325mg
    dosing, so 2 tabs may be used every 4 hours
    instead of every 6 without going over the
    acetaminophen limit.
  • Oxycodone is more regulated, so an outpatient
    prescription cannot be called in a physical
    prescription must be written and received by the
    patient.
  • Hydrocodone is not available in oral formulation
    by itself.
  • Lortab/Vicodin is hydrocodone 5/500mg so each
    tablet comes with more acetaminophen, meaning if
    you use a 2 tablet dose, it cannot be given more
    frequently than q 6 hours.
  • Hydrocodone is less regulated than oxycodone, and
    a prescription containing it may be called in to
    a pharmacy over the phone.

23
Sources
  • 1. Mark Goodman, M.D., Pain Management in
    Obstetrics and Gynecology Grand Rounds, 2006.
    Department of Family Medicine, Creighton
    University.
  • 2. Frederick E. Youngblood, M.D., CME
    Presentation October 14, 2005. Department of
    Anesthesiology, Creighton University.
  • 3. Robert H. Lurie Comprehensive Cancer Center of
    Northwestern University http//endoflife.northwes
    tern.edu Module 4 Pain Management.
  • 4. Journal of Pain and Symptom Management Issue
    29 Vol 1, Jan 2005 pg 2-13.
  • 5. Whitecar, Jonas, Clasen. Managing Pain in
    the Dying Patient. American Family Physician.
    Feb 1,2000/Vol 61, No 3.
Write a Comment
User Comments (0)
About PowerShow.com